Musculoskeletal oncology: state of the art.
The outlook for the patient with sarcoma of the musculoskeletal system has improved dramatically because of recent advances in diagnosis and treatment. These new developments, as discussed in this review, allow greater success in achieving the goals of treatment, which include 1) control of the primary lesions, 2) maintenance of function, and 3) long-term survival.
D001859:Bone Neoplasms / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D016025:Bone Transplantation; D002986:Clinical Trials as Topic; D005266:Femoral Neoplasms / Q000601:surgery; D006801:Humans; D007595:Joint Prosthesis; D009362:Neoplasm Metastasis; D012516:Osteosarcoma / Q000601:surgery / Q000628:therapy; D010166:Palliative Care; D011379:Prognosis; D019736:Prostheses and Implants; D012509:Sarcoma / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D012512:Sarcoma, Ewing / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D012983:Soft Tissue Neoplasms / Q000401:mortality / Q000601:surgery / Q000628:therapy*